Perry Renshaw
27Patents
10h-index
18Co-inventors
72Inventor score
Filing activity: Apr 29, 1996 → Dec 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6572528B2 | Magnetic field stimulation techniques | Human Necessities | 95 | Expired |
| US5850486A | Registration of image data | Physics | 38 | Expired |
| US7282021B2 | Magnetic field stimulation techniques | Human Necessities | 35 | Expired |
| US6617169B2 | Two-dimensional MR spectroscopy techniques | Emerging Cross-Sectional Technologies | 32 | Expired |
| US7033312B2 | Magnetic field stimulation techniques | Human Necessities | 30 | Expired |
| US6898455B2 | Method for providing optimal drug dosage | Human Necessities | 28 | Expired |
| US6104943A | Phased array echoplanar imaging system for fMRI | Physics | 24 | Expired |
| US5958896A | Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure | Human Necessities | 16 | Expired |
| US7737128B2 | Pyrimidines, such as uridine, in treatments for patients with bipolar disorder | Human Necessities | 13 | Expired |
| US6103703A | Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure | Human Necessities | 10 | Expired |
| US6400978B1 | Method and apparatus for detecting mental disorders | Human Necessities | 7 | Expired |
| US6258794A | Treatment of mental conditions including depression | Chemistry; Metallurgy | 5 | Expired |
| US8702582B2 | Magnetic field treatment techniques | Human Necessities | 2 | Active |
| US8575219B2 | Compounds for the treatment of psychiatric or substance abuse disorders | Human Necessities | 2 | Active |
| US8303480B2 | Magnetic field treatment techniques | Human Necessities | 2 | Active |
| US6630127B2 | Method for assessing cortical response to blue light | Human Necessities | 1 | Expired |
| US11583546B2 | Administration of citicoline to improve cognitive performance, attentional performance, and motor function | Human Necessities | 1 | Active |
| US8524665B2 | Use of secretin in treatments of disorders associated with the amygdala | Human Necessities | 1 | Active |
| US8047979B2 | Magnetic field treatment techniques | Human Necessities | 0 | Active |
| US10265317B2 | Combination of creatine, an omega-3 fatty acid, and citicoline | Human Necessities | 0 | Active |
| US7863254B2 | Compounds for the treatment of psychiatric or substance abuse disorders | Human Necessities | 0 | Expired |
| US12115181B2 | Administration of citicoline to improve cognitive performance, attentional performance, and motor function | Human Necessities | 0 | Active |
| US8030294B2 | Compounds for the treatment of psychiatric or substance abuse disorders | Human Necessities | 0 | Active |
| US8897854B2 | Brain phosphorus spectroscopy in bipolar disorder | Human Necessities | 0 | Active |
| US10058552B2 | Combination of creatine, an omega-3 fatty acid, and citicoline | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.